Fabasoft AG

  • WKN: 922985
  • ISIN: AT0000785407
  • Land: Austria

Nachricht vom 19.08.2021 | 15:41

Fabasoft AG: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements

Fabasoft AG / Preliminary announcement on the disclosure of financial statements
19.08.2021 / 15:41
Preliminary announcement of the publication of quarterly reports and quarterly/interim statements transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Fabasoft AG hereby announces that the following financial reports shall be disclosed:

Report Type: Quarterly/ Interim statement within the 1st half-year

Language: German
Date of disclosure: August 27, 2021
Address: https://www.fabasoft.com/finanzberichte

Language: English
Date of disclosure: August 27, 2021
Address: https://www.fabasoft.com/financial_reports


19.08.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Allianz SE: Allianz kündigt Abschluss eines Rückversicherungsvertrages in den USA an

03. Dezember 2021, 07:03

Aktueller Webcast

Deutsche Konsum REIT-AG

FY 2020/2021 Financial Results

16. Dezember 2021

Aktuelle Research-Studie

CEWE Stiftung & Co. KGaA

Original-Research: CEWE Stiftung & Co. KGaA (von GSC Research GmbH): Kaufen

02. Dezember 2021